508 related articles for article (PubMed ID: 18801920)
1. Synergy between gemifloxacin and trimethoprim/sulfamethoxazole against community-associated methicillin-resistant Staphylococcus aureus.
Leonard SN; Kaatz GW; Rucker LR; Rybak MJ
J Antimicrob Chemother; 2008 Dec; 62(6):1305-10. PubMed ID: 18801920
[TBL] [Abstract][Full Text] [Related]
2. Bactericidal activity of orally available agents against methicillin-resistant Staphylococcus aureus.
Kaka AS; Rueda AM; Shelburne SA; Hulten K; Hamill RJ; Musher DM
J Antimicrob Chemother; 2006 Sep; 58(3):680-3. PubMed ID: 16840428
[TBL] [Abstract][Full Text] [Related]
3. Community-acquired methicillin-resistant Staphylococcus aureus in Madrid, Spain: transcontinental importation and polyclonal emergence of Panton-Valentine leukocidin-positive isolates.
Cercenado E; Cuevas O; Marín M; Bouza E; Trincado P; Boquete T; Padilla B; Vindel A
Diagn Microbiol Infect Dis; 2008 Jun; 61(2):143-9. PubMed ID: 18280081
[TBL] [Abstract][Full Text] [Related]
4. Community- and health care-associated methicillin-resistant Staphylococcus aureus: a comparison of molecular epidemiology and antimicrobial activities of various agents.
Tsuji BT; Rybak MJ; Cheung CM; Amjad M; Kaatz GW
Diagn Microbiol Infect Dis; 2007 May; 58(1):41-7. PubMed ID: 17300912
[TBL] [Abstract][Full Text] [Related]
5. Community-onset methicillin-resistant Staphylococcus aureus in an urban HIV clinic.
Skiest D; Brown K; Hester J; Moore T; Crosby C; Mussa HR; Hoffman-Roberts H; Cooper T
HIV Med; 2006 Sep; 7(6):361-8. PubMed ID: 16903980
[TBL] [Abstract][Full Text] [Related]
6. Community-acquired MRSA infections in North Carolina children: prevalence, antibiotic sensitivities, and risk factors.
Shapiro A; Raman S; Johnson M; Piehl M
N C Med J; 2009; 70(2):102-7. PubMed ID: 19489364
[TBL] [Abstract][Full Text] [Related]
7. Determination of the mutant selection window for clindamycin, doxycycline, linezolid, moxifloxacin and trimethoprim/sulfamethoxazole against community-associated meticillin-resistant Staphylococcus aureus (MRSA).
Allen GP; Deshpande LM
Int J Antimicrob Agents; 2010 Jan; 35(1):45-9. PubMed ID: 19910164
[TBL] [Abstract][Full Text] [Related]
8. Comparative activity of telavancin against isolates of community-associated methicillin-resistant Staphylococcus aureus.
Saravolatz LD; Pawlak J; Johnson LB
J Antimicrob Chemother; 2007 Aug; 60(2):406-9. PubMed ID: 17586562
[TBL] [Abstract][Full Text] [Related]
9. Activity of moxifloxacin against intracellular community-acquired methicillin-resistant Staphylococcus aureus: comparison with clindamycin, linezolid and co-trimoxazole and attempt at defining an intracellular susceptibility breakpoint.
Lemaire S; Kosowska-Shick K; Appelbaum PC; Glupczynski Y; Van Bambeke F; Tulkens PM
J Antimicrob Chemother; 2011 Mar; 66(3):596-607. PubMed ID: 21186193
[TBL] [Abstract][Full Text] [Related]
10. Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus.
Rose WE; Poppens PT
J Antimicrob Chemother; 2009 Mar; 63(3):485-8. PubMed ID: 19109338
[TBL] [Abstract][Full Text] [Related]
11. An analysis of a community-acquired pathogen in a Kentucky community: methicillin-resistant Staphylococcus aureus.
Arnold FW; Wojda B
J Ky Med Assoc; 2005 May; 103(5):206-10. PubMed ID: 15918650
[TBL] [Abstract][Full Text] [Related]
12. Community-associated methicillin-resistant and methicillin-sensitive Staphylococcus aureus: skin and soft tissue infections in Hong Kong.
Ho PL; Chuang SK; Choi YF; Lee RA; Lit AC; Ng TK; Que TL; Shek KC; Tong HK; Tse CW; Tung WK; Yung RW;
Diagn Microbiol Infect Dis; 2008 Jul; 61(3):245-50. PubMed ID: 18272316
[TBL] [Abstract][Full Text] [Related]
13. Clinical isolates of Staphylococcus aureus from the Arkhangelsk region, Russia: antimicrobial susceptibility, molecular epidemiology, and distribution of Panton-Valentine leukocidin genes.
Vorobieva V; Bazhukova T; Hanssen AM; Caugant DA; Semenova N; Haldorsen BC; Simonsen GS; Sundsfjord A
APMIS; 2008 Oct; 116(10):877-87. PubMed ID: 19132981
[TBL] [Abstract][Full Text] [Related]
14. The role of primary care prescribers in the diagnosis and management of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
Lawrence KR; Golik MV; Davidson L
Am J Ther; 2009; 16(4):333-8. PubMed ID: 19617720
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial susceptibility and staphylococcal chromosomal cassette mec type in community- and hospital-associated methicillin-resistant Staphylococcus aureus.
LaPlante KL; Rybak MJ; Amjad M; Kaatz GW
Pharmacotherapy; 2007 Jan; 27(1):3-10. PubMed ID: 17192156
[TBL] [Abstract][Full Text] [Related]
16. Trimethoprim-sulfamethoxazole plus topical antibiotics as therapy for acute otitis media with otorrhea caused by community-acquired methicillin-resistant Staphylococcus aureus in children.
Al-Shawwa BA; Wegner D
Arch Otolaryngol Head Neck Surg; 2005 Sep; 131(9):782-4. PubMed ID: 16172354
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of dalbavancin, tigecycline, minocycline, tetracycline, teicoplanin and vancomycin against community-associated and multidrug-resistant hospital-associated meticillin-resistant Staphylococcus aureus.
Huang V; Cheung CM; Kaatz GW; Rybak MJ
Int J Antimicrob Agents; 2010 Jan; 35(1):25-9. PubMed ID: 19900792
[TBL] [Abstract][Full Text] [Related]
18. Simulated antibiotic exposures in an in vitro hollow-fiber infection model influence toxin gene expression and production in community-associated methicillin-resistant Staphylococcus aureus strain MW2.
Pichereau S; Pantrangi M; Couet W; Badiou C; Lina G; Shukla SK; Rose WE
Antimicrob Agents Chemother; 2012 Jan; 56(1):140-7. PubMed ID: 22064533
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic-resistant Staphylococcus aureus in community-acquired pediatric neck abscesses.
Guss J; Kazahaya K
Int J Pediatr Otorhinolaryngol; 2007 Jun; 71(6):943-8. PubMed ID: 17418426
[TBL] [Abstract][Full Text] [Related]
20. In vitro pharmacokinetic/pharmacodynamic activity of NXL103 versus clindamycin and linezolid against clinical Staphylococcus aureus and Streptococcus pyogenes isolates.
Vidaillac C; Parra-Ruiz J; Winterfield P; Rybak MJ
Int J Antimicrob Agents; 2011 Oct; 38(4):301-6. PubMed ID: 21764263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
